As of the latest SEC filings, Virax Biolabs Group Ltd (VRAX) is held by 1 institutional funds. The largest fund shareholder is Blackstone Alternative Multi-Strategy Fund (BXMYX), holding an estimated $5.28 in market value, representing a significant portion of its portfolio.